We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

WARF Signs License Agreement with Pfizer for Human Embryonic Stem Cells

News   May 15, 2009

 
WARF Signs License Agreement with Pfizer for Human Embryonic Stem Cells
 
 
 

RELATED ARTICLES

“Special” CRISPR Permits Gene-editing of Stem Cell Derived Neurons

News

A team of scientists have achieved another CRISPR first, one which may fundamentally alter the way scientists study brain diseases.

READ MORE

Ageing Process Reversed in Rat Brain Stem Cells

News

New research reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse older stem cells to a younger, healthier state.

READ MORE

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE